New possibilities of dry eye syndrome treatment in patients with primary glaucoma
https://doi.org/10.25700/NJG.2019.02.08
Abstract
Purpose: To evaluate the efficiency of Oсuhyl C moisturizing ophthalmic solution in patients with dry eye syndrome (DES) and primary glaucoma.
Methods: The study included 26 patients (47 eyes) with different stages of primary open-angle glaucoma, mean age 68.62±1.76 years. Duration of instillation of hypotensive eye drops with preservatives ranged from 1 year to 35 years. Intraocular pressure (IOP) was compensated prior to the examination. Subjective DES signs assessment included a three-point scale questionnaire: 0 points — no sign, 1 point — periodic occurrence, 2 points — constant presence. The following functional tests were performed in all the patients: the Norn test for the stability of the precorneal tear film, the Shirmer test for assessing the level of total tear production. Examinations were carried out prior to drug administration and after 4 and 8 weeks of its use (sodium hyaluronate 0.12% 1 drop 3 times a day after 10 min after antihypertensive drugs).
Results: All patients noted good tolerability of the drug and no significant side effects. Feeling of a foreign body, dryness and eye redness were significantly decreased after the drug instillations. The initial total tear production on average was 8.94±1.12 mm, after 8 weeks it increased to 11.55±1.01 (p<0.1). The time of the precorneal tear film rupture increased significantly from 8.21±0.31 seconds to 15.06±0.61 (p<0.001).
Conclusion: Ocuhyl C has a positive effect on reducing DES symptoms in patients with primary glaucoma and a long-term use of antihypertensive therapy with preservatives, and can be recommended for clinical use.
About the Authors
T. V. Gavrilova
E.A. Vagner Perm State Medical University
Russian Federation
Russian Federation
Med.Sc.D., Professor, Head of Ophthalmology Department.
26 Petropavlovskaya str., Perm, Russian Federation, 614990
L. I. Solovyova
E.A. Vagner Perm State Medical University
Russian Federation
Russian Federation
Ph.D., Associate Professor of Ophthalmology Department.
26 Petropavlovskaya str., Perm, Russian Federation, 614990
F. G. Mugumova
E.A. Vagner Perm State Medical University
Russian Federation
Russian Federation
Resident of Ophthalmology Department.
26 Petropavlovskaya str., Perm, Russian Federation, 614990
References
1. Egorov E.A., Alekseev V.N. Patogenez i lechenie pervichnoi otkrytougol’noi glaukomy [Pathogenesis and treatment of primary openangle glaucoma]. Moscow: GEOTAR-Media; 2017. 217 p. (In Russ.).
2. Neroev V.V., Kiseleva O.A., Bessmertnyi A.M. Main results of multicentral research of epidemiological peculiarities of primary open-angle glaucoma. Russian Ophthalmological Journal. 2013;3:4-7. (In Russ.).
3. Solovyeva L.I., Gavrilova T.V., Sobyanin N.A. Antiglaucoma work in Perm: problems and ways of decision. Perm medical journal. 2018; 25(1):75-81. (In Russ.).
4. Brzheskii V.V. Glaucoma and dry eye syndrome. Moscow: Borges; 2018. 228 p. (In Russ.).
5. Murbe J., Benitez del Castillo J.M., Chen Zhuo L., Berta A. et al. The Madrid triple classification of dry eye. Arch Soc Esp Oftalmol. 2003; 78:(587-594).
6. Tincani A., Andreoli L., Cavazzana I. et al. Novel aspects of Sjogren’s syndrome in 2012. BMC Med. 2013; 11:93.
7. Rolando M., Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol. 2001; 45(2):203-210.
8. Egorova G.B., Averich V.V. The reduction of cytotoxical effect of preservative in the composition of ophthalmohypotensive preparations with the help of tear-replacing therapy. Vestnik oftalmologii. 2018; 3:48-56. (In Russ.).
9. Erb C., Gast U., Schremmer D. German register for glaucoma patients with dry eye. I Basic outcome with respect to dry eye. Graefe’s Arch Clin Exp Ophthalmol. 2008; 246(11):1593-1601.
10. Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008; 86(7): 716-726.
11. Erichev V.P., Ambartsumyan K.H. The preservatives and secondary dry eye syndrome at topical long-term open-angle glaucoma therapy. Glaucoma. 2011; 2:60-64. (In Russ.).
12. Pillunat L.E., Erb C., Ropo A., Kimmich F. et al. Preservative-free combination of tafluprost 0,0015% and timolol 0,5% in patients with open-angle glaucoma and ocular hypertension: results of an openlabel observational study. Clin Ophthalmol. 2017; 11:1051-1064.
13. Chung H., Lee S.K., Cristol M. et al. Impact of short term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin. Mol Vis. 2006; 12:415-421.
14. Pavliv O.B., Diogenova M.A. Using of the preparations on the basis of gyaluronic acid in the treatment of «dry eye» syndrome in patients after phacoemulsification. Ophthalmology. Eastern Europe. 2012; 3:151-156. (In Russ.).
15. Stepanyants A.B., Feoktistiva M.A., Shalgina P.S., Kurochkina E.Y. Analysis of Ocuhyl C eyedrops effectiveness in patients after cataract ultrasound phacoemulsification. Otrazhenie. 2018; 2:43-45. (In Russ.).
Review
For citations:
Gavrilova T.V., Solovyova L.I., Mugumova F.G. New possibilities of dry eye syndrome treatment in patients with primary glaucoma. National Journal glaucoma. 2019;18(2):70-75. (In Russ.) https://doi.org/10.25700/NJG.2019.02.08
Views:
619
Email this article 